Abstract
Spheroidal cancer cell cultures have been used to enrich cancer stem cells (CSC), which are thought to contribute to important clinical features of tumors. This study aimed to map the regulatory networks driven by circular RNAs (circRNAs) in CSC-enriched colorectal cancer (CRC) spheroid cells. The spheroid cells established from two CRC cell lines acquired stemness properties in pluripotency gene expression and multi-lineage differentiation capacity. Genome-wide sequencing identified 1503 and 636 circRNAs specific to the CRC parental and spheroid cells, respectively. In the CRC spheroids, algorithmic analyses unveiled a core network of mRNAs involved in modulating stemness-associated signaling pathways, driven by a circRNA–microRNA (miRNA)–mRNA axis. The two major circRNAs, hsa_circ_0066631 and hsa_circ_0082096, in this network were significantly up-regulated in expression levels in the spheroid cells. The two circRNAs were predicted to target and were experimentally shown to down-regulate miR-140-3p, miR-224, miR-382, miR-548c-3p and miR-579, confirming circRNA sponging of the targeted miRNAs. Furthermore, the affected miRNAs were demonstrated to inhibit degradation of six mRNA targets, viz. ACVR1C/ALK7, FZD3, IL6ST/GP130, SKIL/SNON, SMAD2 and WNT5, in the CRC spheroid cells. These mRNAs encode proteins that are reported to variously regulate the GP130/Stat, Activin/Nodal, TGF-β/SMAD or Wnt/β-catenin signaling pathways in controlling various aspects of CSC stemness. Using the CRC spheroid cell model, the novel circRNA–miRNA–mRNA axis mapped in this work forms the foundation for the elucidation of the molecular mechanisms of the complex cellular and biochemical processes that determine CSC stemness properties of cancer cells, and possibly for designing therapeutic strategies for CRC treatment by targeting CSC.
Highlights
Cancer treatment faces two major challenges, viz. recurrence and metastasis, both attributed to the presence of cancer stem cells (CSCs) in the tumor [1]
To generate colorectal cancer (CRC) spheroids, two CRC cell lines, HCT-15 and WiDr, both derived from colorectal adenocarcinoma, were cultured in a serum-free medium supplemented with growth factors on polyhydroxyethylmethacrylate-coated culture flasks
The ability of the cells to differentiate into ectodermic and mesodermic lineages supported the pluripotency of the CSC in the spheroids, as was reported for CRC cancer stem cell-like population to differentiate into mucin-producing goblet cells, enterocyte-like and neuroendocrine-like cells [18]
Summary
Cancer treatment faces two major challenges, viz. recurrence and metastasis, both attributed to the presence of cancer stem cells (CSCs) in the tumor [1]. Recurrence and metastasis, both attributed to the presence of cancer stem cells (CSCs) in the tumor [1]. In a postulated “bottom-up” model of the genesis of colorectal cancer (CRC), CRC stem cells (CrCSCs) are thought to arise from the intestinal stem cells residing at the bottom of the colonic crypts due to the accumulation of mutations; CrCSCs harboring the mutations subsequently repopulate the crypts, leading to tumor formation [5,6,7]. The unique features of CSCs include self-renewal, multi-lineage differentiation abilities, dysregulated proliferation control, enhanced tumorigenicity and chemo- and radio-therapeutic resistance [8,9,10]. Apart from demonstrating higher tumorigenicity in in vivo models [16,17], spheroid cells exhibit CSC-like features, including enhanced chemoresistance, metastatic and differentiation ability [18,19,20,21]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.